Bxcl501: Clinical Trials

1 trial of Bxcl501, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Completed 1

Follow Bxcl501: new trials by email Literature Review of Bxcl501 trials Research Report on Bxcl501

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder
Sublingual film containing Igalmi - Bipolar Disorder, Schizophrenia
Phase 4CompletedBioXcel Therapeutics Inc292023-10-022026-08-11

Conditions studied

Bipolar Disorder (1)  ·  Psychomotor Agitation (1)  ·  Psychotic Disorders (1)  ·  Schizophrenia (1)

Sponsors

BioXcel Therapeutics Inc (1)

Countries

United States (1)

Top investigators

BioXcel MM, MD (1)